Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

Akkaya, CENGİZ; Kirli, SELÇUK; EKER, SALİH; Cangur, Sengul; Canbazoglu, Mustafa; Sarandol, ASLI

doi:10.1080/10177833.2010.11790673

Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

Atıf İçin Kopyala

Akkaya C., Kirli S., EKER S. S., Cangur S., Canbazoglu M., Sarandol A.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.20, sa.4, ss.274-287, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20 Sayı: 4
Basım Tarihi: 2010
Doi Numarası: 10.1080/10177833.2010.11790673
Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.274-287
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Objective: This paper aims to compare the efficacy and safety of three widely used antidepressants, sertraline, reboxetine, a sertraline-reboxetine combination and venlafaxine, in the treatment of MDD and their effect on depressive symptoms in MDD patients.